List of Excipients in API tenofovir alafenamide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tenofovir alafenamide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Gilead Sciences Inc | VEMLIDY | tenofovir alafenamide | 61958-2301 | CELLULOSE, MICROCRYSTALLINE | |
| Gilead Sciences Inc | VEMLIDY | tenofovir alafenamide | 61958-2301 | CROSCARMELLOSE SODIUM | |
| Gilead Sciences Inc | VEMLIDY | tenofovir alafenamide | 61958-2301 | FERRIC OXIDE YELLOW | |
| Gilead Sciences Inc | VEMLIDY | tenofovir alafenamide | 61958-2301 | LACTOSE MONOHYDRATE | |
| Gilead Sciences Inc | VEMLIDY | tenofovir alafenamide | 61958-2301 | MAGNESIUM STEARATE | |
| Gilead Sciences Inc | VEMLIDY | tenofovir alafenamide | 61958-2301 | POLYETHYLENE GLYCOL 3350 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for tenofovir alafenamide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tenofovir alafenamide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
tenofovir alafenamide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
tenofovir alafenamide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
tenofovir alafenamide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tenofovir alafenamide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
tenofovir alafenamide drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
tenofovir alafenamide drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
tenofovir alafenamide drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tenofovir alafenamide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | tenofovir alafenamide | 61958-2301 |
| >Company | >Ingredient | >NDC |
tenofovir alafenamide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
